Enveric Biosciences Inc Stock
Enveric Biosciences Inc Stock price
Key metrics
| Market capitalization | $3.26m |
| Enterprise Value | $-240.00k |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | 0.02 |
| P/B ratio (TTM) P/B ratio | 0.53 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-10.21m |
| Free Cash Flow (TTM) Free Cash Flow | $-9.98m |
| Cash position | $3.50m |
Is Enveric Biosciences Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.
Enveric Biosciences Inc Stock Analysis
Analyst Opinions
1 Analyst has issued a forecast Enveric Biosciences Inc:
Analyst Opinions
1 Analyst has issued a forecast Enveric Biosciences Inc:
Financial data from Enveric Biosciences Inc
| Jun '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.35 -0.35 |
20%
20%
|
|
| EBITDA | -9.86 -9.86 |
52%
52%
|
EBIT (Operating Income) EBIT | -10 -10 |
52%
52%
|
| Net Profit | -11 -11 |
52%
52%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Enveric Biosciences Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Enveric Biosciences Inc Stock News
Company Profile
Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.
| Head office | United States |
| CEO | Joseph Tucker |
| Employees | 7 |
| Founded | 1994 |
| Website | www.enveric.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
